Infimer (Israel) Price Prediction
| INFR Stock | ILA 20,890 15,890 317.80% |
Oversold Vs Overbought
43
Oversold | Overbought |
Using Infimer hype-based prediction, you can estimate the value of Infimer from the perspective of Infimer response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Infimer to buy its stock at a price that has no basis in reality. In that case, they are not buying Infimer because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Infimer after-hype prediction price | ILA 20890.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Infimer |
Infimer After-Hype Price Prediction Density Analysis
As far as predicting the price of Infimer at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Infimer or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Infimer, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Infimer Estimiated After-Hype Price Volatility
In the context of predicting Infimer's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Infimer's historical news coverage. Infimer's after-hype downside and upside margins for the prediction period are 1,044 and 2,109,890, respectively. We have considered Infimer's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Infimer is out of control at this time. Analysis and calculation of next after-hype price of Infimer is based on 3 months time horizon.
Infimer Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Infimer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Infimer backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Infimer, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
123.22 | 343.92 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
20,890 | 20,890 | 0.00 |
|
Infimer Hype Timeline
Infimer is currently traded for 20,890on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Infimer is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 123.22%. %. The volatility of related hype on Infimer is about 0.0%, with the expected price after the next announcement by competition of 20,890. About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 5.3. Infimer last dividend was issued on the 16th of March 2015. The entity had 1:2 split on the 8th of March 2020. Assuming the 90 days trading horizon the next forecasted press release will be uncertain. Check out Infimer Basic Forecasting Models to cross-verify your projections.Infimer Related Hype Analysis
Having access to credible news sources related to Infimer's direct competition is more important than ever and may enhance your ability to predict Infimer's future price movements. Getting to know how Infimer's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Infimer may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ESLT | Elbit Systems | 0.00 | 0 per month | 0.97 | 0.14 | 4.09 | (2.03) | 8.80 | |
| BEZQ | Bezeq Israeli Telecommunication | 0.00 | 0 per month | 0.92 | 0.19 | 3.25 | (1.90) | 8.84 | |
| POLI | Bank Hapoalim | 0.00 | 0 per month | 1.03 | 0.18 | 2.76 | (1.62) | 5.34 | |
| TEVA | Teva Pharmaceutical Industries | 0.00 | 0 per month | 0.00 | (0.09) | 3.08 | (3.32) | 8.75 | |
| LUMI | Bank Leumi Le Israel | 0.00 | 0 per month | 1.10 | 0.22 | 2.58 | (2.11) | 6.28 |
Infimer Additional Predictive Modules
Most predictive techniques to examine Infimer price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Infimer using various technical indicators. When you analyze Infimer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Infimer Predictive Indicators
The successful prediction of Infimer stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Infimer, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Infimer based on analysis of Infimer hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Infimer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Infimer's related companies.
Story Coverage note for Infimer
The number of cover stories for Infimer depends on current market conditions and Infimer's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Infimer is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Infimer's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |